Sean Ford

USPTO Granted Patents = 13 (Patent Applications = 6)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 4)

Average Co-Inventor Count = 4.1

ph-index = 4

Forward Citations = 51(Granted Patents)

Location History:

Lake Zurich, IL (US) (2011)
Carlsbad, CA (US) (2016 - 2018)
Oceanside, CA (US) (2012 - 2024)

Company Filing History:

6 out of 25

Genmark Diagnostics, Inc.

patents

4 out of 621

Roche Molecular Systems, Inc.

patents

2 out of 2,075

Siemens Medical Solutions Usa, Inc.

patents

4. 1 out of 124

Advanced Liquid Logic, Inc.

where one patent can have more than one assignee

Years Active: 2011-2024

Loading Chart...

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12000847 - Instrument for processing cartridge for performing assays in a closed sample preparation and reaction system (2024-06-04),

2. 11952618 - Integrated multiplex target analysis (2024-04-09),

3. 11300578 - Instrument for processing cartridge for performing assays in a closed sample preparation and reaction system (2022-04-12),

4. 11156508 - Devices and methods for monitoring and controlling temperature in a microfluidic environment (2021-10-26),

5. D881409 - Biochip cartridge (2020-04-14),

6. 10495656 - Integrated multiplex target analysis (2019-12-03),

7. 10005080 - Instrument and cartridge for performing assays in a closed sample preparation and reaction system employing electrowetting fluid manipulation (2018-06-26),

8. 9957553 - Integrated multiplex target analysis (2018-05-01),

9. 9945738 - Devices and methods for monitoring and controlling temperature in a microfluidic environment (2018-04-17),

10. 9891215 - Methods for the electrochemical treatment of self-assembled monolayers (2018-02-13),

11. 9421318 - Blood bag systems for separation of whole blood and methods of use thereof (2016-08-23),

12. 8173073 - Portable microfluidic radiosynthesis system for positron emission tomography biomarkers and program code (2012-05-08),

13. 8071035 - Microfluidic radiosynthesis system for positron emission tomography biomarkers (2011-12-06),

Title: The Innovative Journey of Sean Ford: A Trailblazer in Diagnostics

Introduction: Sean Ford, based in Oceanside, California, has made significant contributions to the field of diagnostics through his innovative inventions. With a prolific portfolio of 13 patents, he is recognized for his inventive prowess and dedication to advancing diagnostic technologies.

Latest Patents: Sean Ford's latest works include a groundbreaking patent for an instrument designed for processing cartridges that perform assays in a closed sample preparation and reaction system. This diagnostic system integrates an instrument connected to a client device, featuring a sample processing bay. A notable aspect of this system is its sophisticated software architecture, which comprises instrument software (ISW) that processes assay definition files (ADF) and generates analytical reports based on sensor scan data. Another significant invention spearheaded by Ford is the concept of integrated multiplex target analysis, focusing on the creation of biochip cartridges and instruments capable of detecting and analyzing target analytes in patient samples.

Career Highlights: Sean has held key positions in prestigious companies such as GenMark Diagnostics, Inc. and Roche Molecular Systems, Inc. His work in these companies has been instrumental in pushing the boundaries of diagnostic research and development.

Collaborations: Throughout his career, Sean has collaborated with notable professionals, including Jon Faiz Kayyem and Jayashankar Srinivasan. These partnerships have undoubtedly enriched his innovative journey and propelled advancements in healthcare technology.

Conclusion: Sean Ford exemplifies the spirit of innovation in the field of diagnostics. His groundbreaking patents, career achievements, and collaborative efforts with other experts illustrate his commitment to enhancing patient care through technology. As he continues to develop new solutions for complex challenges in diagnostics, Sean remains a vital contributor to the industry's evolution.

This text is generated by artificial intelligence and may not be accurate.